ICD Co. Ltd (040910) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ICD Co. Ltd (040910) has a cash flow conversion efficiency ratio of -0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.69 Billion ≈ $-3.86 Million USD) by net assets (₩93.82 Billion ≈ $63.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ICD Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how ICD Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 040910 current and long-term liabilities for a breakdown of total debt and financial obligations.
ICD Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ICD Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hotel Mandarine Regency Tbk PT
JK:HOME
|
-0.004x |
|
Sambo Motors Co. Ltd
KQ:053700
|
0.031x |
|
ADYTON RESOURCES CORP.
F:701
|
0.004x |
|
Elin Electronics Limited
NSE:ELIN
|
0.017x |
|
Future Health Esg Corp
NASDAQ:FHLT
|
0.653x |
|
Shanghai Yaohua Pilkington Glass Group Co Ltd B
SHG:900918
|
0.039x |
|
Northwest Copper Corp
V:NWST
|
-0.017x |
|
Ferronordic AB (publ)
ST:FNM
|
-0.029x |
Annual Cash Flow Conversion Efficiency for ICD Co. Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of ICD Co. Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see ICD Co. Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩96.98 Billion ≈ $65.72 Million |
₩-27.81 Billion ≈ $-18.85 Million |
-0.287x | -2389.05% |
| 2023-12-31 | ₩127.18 Billion ≈ $86.19 Million |
₩-1.47 Billion ≈ $-993.12K |
-0.012x | +87.65% |
| 2022-12-31 | ₩153.25 Billion ≈ $103.85 Million |
₩-14.29 Billion ≈ $-9.69 Million |
-0.093x | -173.78% |
| 2021-12-31 | ₩167.94 Billion ≈ $113.81 Million |
₩21.23 Billion ≈ $14.39 Million |
0.126x | -54.19% |
| 2020-12-31 | ₩179.47 Billion ≈ $121.63 Million |
₩49.53 Billion ≈ $33.57 Million |
0.276x | +69.34% |
| 2019-12-31 | ₩147.06 Billion ≈ $99.66 Million |
₩23.97 Billion ≈ $16.24 Million |
0.163x | -28.22% |
| 2018-12-31 | ₩131.40 Billion ≈ $89.05 Million |
₩29.83 Billion ≈ $20.22 Million |
0.227x | +356.30% |
| 2017-12-31 | ₩134.14 Billion ≈ $90.91 Million |
₩-11.88 Billion ≈ $-8.05 Million |
-0.089x | -9.61% |
| 2016-12-31 | ₩112.69 Billion ≈ $76.37 Million |
₩-9.11 Billion ≈ $-6.17 Million |
-0.081x | -433.22% |
| 2015-12-31 | ₩90.88 Billion ≈ $61.59 Million |
₩2.20 Billion ≈ $1.49 Million |
0.024x | -92.01% |
| 2013-12-31 | ₩105.42 Billion ≈ $71.44 Million |
₩32.00 Billion ≈ $21.69 Million |
0.304x | -- |
About ICD Co. Ltd
ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, … Read more